A Coalition Steps In: Filling the Vaccine Guidance Gap

A coalition of leading medical groups has issued its own guidance on immunizations for flu, COVID-19, and RSV. The American Medical Association (AMA) and the American Academy of Pediatrics, among others, have come together to provide clear, credible advice in a landscape increasingly politicized by vaccine policy.

The coalition’s guidance echoes the long-standing consensus on vaccine efficacy: these immunizations continue to offer meaningful protection against severe illness, hospitalization, and death. Recent scientific studies have not raised new health concerns related to vaccines for these viruses. Instead, evidence remains robust in support of vaccination.

This development comes after a federal government vaccine policy overhaul that has left many scratching their heads. The Trump administration’s decision to pull back on longstanding recommendations for virus protection and routine children’s vaccinations was met with criticism from medical associations. The changes ran counter to scientific consensus, and a federal judge later suspended many of the administration’s measures.

The absence of updated vaccine recommendations from the Centers for Disease Control and Prevention (CDC) has left healthcare providers and patients in uncertainty. Typically, the CDC provides expert advice on vaccination recommendations through its independent advisers. However, the coalition’s guidance is a welcome one – as AMA president-elect Sandra Fryhofer pointed out: “Patients need and deserve vaccine recommendations that are clear, credible, and based on the best available scientific evidence, so they can make informed vaccine decisions for themselves and for their families.”

The coalition’s independent review has been published online, providing a resource for those seeking reliable guidance. The question now is what this means for the future of vaccine policy in the US: will the coalition’s guidance serve as a stopgap measure until the CDC provides its own recommendations, or will it signal a more fundamental shift in how vaccination advice is developed and disseminated?

The need for clear, credible advice on vaccination has never been greater. As Americans navigate an increasingly complex healthcare landscape, they deserve to have faith that their medical professionals are guiding them with evidence-based guidance.

Influenza alone caused 32 million to 52 million cases, 390,000 hospitalizations, and 24,000 deaths in the US during the 2025-2026 respiratory virus season. COVID-19 and RSV also exact a significant toll – one that underscores the importance of vaccination. For now, at least, this coalition’s guidance offers a beacon of hope for those seeking reliable advice on immunizations.

As we move forward, it will be essential to monitor how this development plays out – and whether it represents a turning point in the long and often contentious history of vaccine policy in the US.